Meng-Ju Wu
Harvard University
H-index: 12
North America-United States
Top articles of Meng-Ju Wu
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer | Cell Metabolism | Yingsheng Zhang Meng-Ju Wu Wan-Chi Lu Yi-Chuan Li Chun Ju Chang | 2024/1/2 |
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity | Nature | Christina K Baumgartner Hakimeh Ebrahimi-Nik Arvin Iracheta-Vellve Keith M Hamel Kira E Olander | 2023/10/26 |
Immunometabolism at the crossroads of obesity and cancer—a Keystone Symposia report | Annals of the New York Academy of Sciences | Jennifer Cable Jeffrey C Rathmell Erika L Pearce Ping‐Chih Ho Marcia C Haigis | 2023/5 |
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers | Nature Cancer | Lei Shi William Shen Mindy I Davis Ke Kong Phuong Vu | 2023/3 |
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer | Annals of Oncology | Jacob E Berchuck Francesco Facchinetti Daniel F DiToro Islam Baiev Umair Majeed | 2022/12/1 |
EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion–Positive CholangiocarcinomaCombination Treatment in FGFR2 Fusion Cholangiocarcinoma | Cancer Discovery | Qibiao Wu Yuanli Zhen Lei Shi Phuong Vu Patricia Greninger | 2022/5/2 |
Mutant-IDH inhibits Interferon-TET2 signaling to promote immunoevasion and tumor maintenance in cholangiocarcinoma | Cancer Discovery | Meng-Ju Wu Lei Shi Juan Dubrot Joshua Merritt Vindhya Vijay | 2022/3/8 |
Biology of IDH Mutant Cholangiocarcinoma | Hepatology | Meng-Ju Wu Lei Shi Joshua Merritt Andrew X Zhu Nabeel Bardeesy | 2022/2/28 |
TET2 directs mammary luminal cell differentiation and endocrine response | Nature Communications | Miran Kim Meng-Ju Wu Yingsheng Zhang Jer-Yen Yang Chun-Ju Chang | 2020/9/15 |
Co-Authors
